These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS. Youhnovski N, Michon J, Latour S, Mess JN, Bergeron A, Furtado M, Rufiange M, Guibord P, Lefebvre M, Macarthur RB, Garofolo F. Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350 [Abstract] [Full Text] [Related]
3. UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic study. Delavenne X, Juthier L, Pons B, Mariat C, Basset T. Clin Chim Acta; 2011 Jan 14; 412(1-2):59-65. PubMed ID: 20937266 [Abstract] [Full Text] [Related]
5. Development of a high pressure liquid chromatography method for the determination of mycophenolic acid and its glucuronide metabolite in small volumes of plasma from paediatric patients. Watson DG, Araya FG, Galloway PJ, Beattie TJ. J Pharm Biomed Anal; 2004 Apr 01; 35(1):87-92. PubMed ID: 15030883 [Abstract] [Full Text] [Related]
7. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS. Kehler JR, Bowen CL, Boram SL, Evans CA. Bioanalysis; 2010 Aug 01; 2(8):1461-8. PubMed ID: 21083346 [Abstract] [Full Text] [Related]
8. Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay. Kuhn J, Prante C, Kleesiek K, Götting C. Clin Biochem; 2009 Jan 01; 42(1-2):83-90. PubMed ID: 18996104 [Abstract] [Full Text] [Related]
9. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. D'Arienzo CJ, Ji QC, Discenza L, Cornelius G, Hynes J, Cornelius L, Santella JB, Olah T. Bioanalysis; 2010 Aug 01; 2(8):1415-22. PubMed ID: 21083342 [Abstract] [Full Text] [Related]
10. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods. Abu-Rabie P, Spooner N. Bioanalysis; 2010 Aug 01; 2(8):1373-84. PubMed ID: 21083338 [Abstract] [Full Text] [Related]
13. Sensitive determination of a drug candidate in dried blood spots using a TLC-MS interface integrated into a column-switching LC-MS/MS system. Heinig K, Wirz T, Gajate-Perez A. Bioanalysis; 2010 Nov 01; 2(11):1873-82. PubMed ID: 21083495 [Abstract] [Full Text] [Related]
15. Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Jain AB, Hamad I, Zuckerman S, Zhang S, Warty VS, Fung JJ, Venkataramanan R. Liver Transpl Surg; 1999 Mar 01; 5(2):101-6. PubMed ID: 10071348 [Abstract] [Full Text] [Related]
20. Validation of a high-sensitivity assay for zatebradine in dried blood spots of human blood at pg/ml concentrations using HILIC-MS/MS. Michi M, Ferrari L. Bioanalysis; 2010 Nov 01; 2(11):1863-71. PubMed ID: 21083494 [Abstract] [Full Text] [Related] Page: [Next] [New Search]